VivoSeq
Other

Cigarette Smoker

0

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Cigarette Smoker is an early-stage landscape with 0 programs across 2 companies. The most active players are Novartis, RAI Services Company.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

PreclinicalR

RAI Services Company

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

11

clinical trials

Completed7 · 64%
Unknown status2 · 18%
Terminated1 · 9%
Not yet recruiting1 · 9%

Clinical Trials

Trial Activity

11 trials

A Consumer Use Behavior Study to Measure the Puffing Topography of Heated Tobacco Products (Glo and Glo Plus)
Not yet recruiting·RRAI Services Company·Preclinical·NCT07677280·200 enrolled
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
Completed·Novartis logoNovartis·Phase 2·NCT00736047·200 enrolled
Baclofen Effects in Cigarette Smokers
Completed·UUniversity of Pennsylvania·Phase 2·NCT01821560·44 enrolled
Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers
Completed·SSwedish Match AB·Phase 4·NCT00843622·250 enrolled
Maintaining Abstinence in Chronic Cigarette Smokers - 1
Completed·National Institute on Drug Abuse (NIDA)·Phase 2·NCT00087880·407 enrolled
A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers
Completed·UUniversity of North Carolina, Chapel Hill·Phase 1·NCT00924768·12 enrolled
Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
Completed·YYale University·Phase 1/2·NCT00502216·40 enrolled
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
Completed·AAchieve Life Sciences·Phase 3·NCT06435221·479 enrolled
Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.
Terminated·UUniversity of North Carolina, Chapel Hill·Phase 1·NCT03023397·12 enrolled
A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.
Unknown status·HHadassah Medical Organization·N/A·NCT00396669·24 enrolled
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
Unknown status·HHadassah Medical Organization·N/A·NCT00429208·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)